prognostic indicators

Research in Review

Frailty Screening May Improve Outcomes for Older Surgical Patients

02/13/2017

JCP Editors

The utilization of a novel preoperative frailty screening system reduced mortality up to 365 days postsurgery and may serve as an easily implementable tool for assessing older surgical patients, according to research...

The...

02/13/2017

Journal of Clinical Pathways

Research in Review

Precision Medicine Approach Effective in Evaluating Pediatric Brain Tumors

01/20/2017

JCP Editors

A combination of genomic assays could be an effective precision medicine approach for clinical diagnosis, prognosis, and treatment guidance of pediatric brain tumors, according to new research published in...

A...

01/20/2017

Journal of Clinical Pathways

Research in Review

Identifying Risk of All-Cause Mortality In Men Being Treated for Prostate Cancer

01/17/2017

JCP Editors

Men being treated for prostate cancer who are at higher risk of dying as a result of treatment failure can be identified prior to PSA recurrence using a surrogate endpoint, according to a study published in JAMA...

Men...

01/17/2017

Journal of Clinical Pathways

Research in Review

Emotional Distress May Lead to Unnecessary Treatment for Prostate Cancer

01/11/2017

JCP Editors

Men diagnosed with prostate cancer may become distressed and consequently choose unnecessarily aggressive treatment options, according to a new study published in the Journal of Oncology. Prostate cancer is a highly...

Men...

01/11/2017

Journal of Clinical Pathways

Research in Review

Switching From Docetaxel to Paclitaxel and Bevacizumab Improves PFS in NSCLC

12/08/2016

JCP Editors

Patients with non-squamous non-small cell lung cancer (NSCLC) have improved progression-free survival (PFS) if they switch from docetaxel to paclitaxel and bevacizumab treatments, according to new...

...

12/08/2016

Journal of Clinical Pathways

Research in Review

Veliparib Effectiveness for NSCLC Linked to Smoking-Related Genetic Signature

12/06/2016

JCP Editors

Tobacco users with non-small cell lung cancer (NSCLC) have genetic alterations in their tumors that may underlie their increased responsiveness to veliparib, according to new research. ----- Related...

...

12/06/2016

Journal of Clinical Pathways

Research in Review

Robot-Assisted Radical Prostatectomy Leads to Greater Treatment-Free Survival Than Open Radical Prostatectomy

11/15/2016

JCP Editors

Robot-assisted radical prostatectomy (RARP) has comparable health outcomes and fewer associated adverse events than open radical prostatectomy (ORP), according to results published in the Journal of...

...

11/15/2016

Journal of Clinical Pathways

Research in Review

Analysis Finds Tocilizumab Superior to Conventional DMARDs in RA

11/15/2016

JCP Editors

A comparative effectiveness analysis of biologics for rheumatoid arthritis (RA) showed that tocilizumab monotherapy and tocilizumab plus methotrexate were superior to conventional disease-modifying antirheumatic...

A...

11/15/2016

Journal of Clinical Pathways

Research in Review

Tailored Dose-Dense Chemotherapy Does Not Improve RFS in Early Breast Cancer

11/10/2016

JCP Editors

The use of tailored dose-dense chemotherapy compared with standard adjuvant chemotherapy does not result in significant improvement in high-risk early breast cancer recurrence-free survival (RFS), according to a...

The...

11/10/2016

Journal of Clinical Pathways

Research in Review

Improved Survival from Neoadjuvant Chemotherapy for Soft-Tissue Sarcoma

11/10/2016

JCP Editors

Neoadjuvant chemotherapy with epirubicin plus ifosfamide improves outcomes in patients with soft tissue sarcoma of the trunk or extremities who are at high-risk of recurrence, according to a study presented at the...

...

11/10/2016

Journal of Clinical Pathways